Inhibikase Therapeutics, Inc. (IKT)
2.43
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 11:41
Inhibikase Therapeutics Price : 2.43 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 2.45 | 2.525 | 2.43 | 2.43 | 310497.0 |
| Sep 04, 2026 | 2.49 | 2.55 | 2.475 | 2.50 | 246963.0 |
| Sep 03, 2026 | 2.50 | 2.61 | 2.46 | 2.52 | 564219.0 |
| Sep 02, 2026 | 2.39 | 2.535 | 2.39 | 2.50 | 379048.0 |
| Sep 01, 2026 | 2.30 | 2.405 | 2.27 | 2.38 | 523237.0 |
| Aug 31, 2026 | 2.41 | 2.44 | 2.30 | 2.31 | 329873.0 |
| Aug 28, 2026 | 2.48 | 2.48 | 2.371 | 2.41 | 307960.0 |
| Aug 27, 2026 | 2.48 | 2.50 | 2.40 | 2.47 | 202088.0 |
| Aug 26, 2026 | 2.50 | 2.51 | 2.430 | 2.49 | 244699.0 |
| Aug 25, 2026 | 2.53 | 2.54 | 2.46 | 2.50 | 453436.0 |
| Aug 24, 2026 | 2.41 | 2.54 | 2.345 | 2.50 | 735926.0 |
| Aug 21, 2026 | 2.38 | 2.415 | 2.37 | 2.39 | 309320.0 |
| Aug 20, 2026 | 2.45 | 2.47 | 2.33 | 2.35 | 539987.0 |
| Aug 19, 2026 | 2.44 | 2.515 | 2.43 | 2.45 | 644989.0 |
| Aug 18, 2026 | 2.36 | 2.41 | 2.31 | 2.40 | 343969.0 |
| Aug 17, 2026 | 2.41 | 2.42 | 2.32 | 2.39 | 489781.0 |
| Aug 14, 2026 | 2.39 | 2.435 | 2.37 | 2.41 | 227885.0 |
| Aug 13, 2026 | 2.43 | 2.46 | 2.33 | 2.41 | 360729.0 |
| Aug 12, 2026 | 2.38 | 2.47 | 2.38 | 2.40 | 296947.0 |
| Aug 11, 2026 | 2.48 | 2.515 | 2.41 | 2.45 | 580836.0 |
| Aug 10, 2026 | 2.44 | 2.525 | 2.42 | 2.46 | 479216.0 |
| Aug 07, 2026 | 2.38 | 2.475 | 2.38 | 2.47 | 386846.0 |
| Aug 06, 2026 | 2.39 | 2.49 | 2.385 | 2.41 | 422921.0 |
| Aug 05, 2026 | 2.46 | 2.50 | 2.33 | 2.40 | 1.109M |
| Aug 04, 2026 | 2.25 | 2.465 | 2.24 | 2.44 | 1.255M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.89 |
| Alnylam Pharmaceuticals, Inc. | 255.76 |
| Anika Therapeutics, Inc. | 20.96 |
| Savara, Inc. | 5.405 |
| Vericel Corp. | 38.91 |
Price Related Metrics
| Price to Book Value | 2.092 |
| Earnings Yield | -17.96% |
| Market Cap | 320.84M |